Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus
Alimentary Pharmacology & Therapeutics2017Vol. 45(6), pp. 801–813
Citations Over TimeTop 10% of 2017 papers
Lucine Vuitton, Laurent Peyrin‐Biroulet, J.F. Colombel, Benjamin Pariente, Guillaume Pineton de Chambrun, Alissa Walsh, Julián Panés, Simon Travis, J. Y. Mary, Philippe Marteau
Abstract
These international recommendations represent the first consensus on measurement indices for endoscopic outcomes in ulcerative colitis. They should be subject to prospective testing in clinical trials of ulcerative colitis.
Related Papers
- THE EXPERIMENTAL STUDY OF THE RELATED CYTOKINES FOR IN PATIENTS WITH ULCERATIVE COLITIS.(2005)
- Investigation of Serum NO Levels in Patients With Ulcerative Colitis(2002)
- Determination of plasma P-selection in patients with ulcerative colitis and their clinical significance(2004)
- The severity correlation of TNF-α,IL-6 and IL-8 levels in plasma in patients with ulcerative colitis and their clinical significances(2008)
- → To study on nutritional status in patients with ulcerative colitis(2023)